Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05735639

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) - a Multi-centre Assessor-blind Randomised-controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
6,660 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots in the deep veins happen in around 1 in 50 people after endovenous operations. A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it can cause problems with the lung' ability to move oxygen from the air into the blood and may, in rare cases, be life threatening. Varicose vein procedures may carry a slightly higher risk of blood clot formation, and we are currently unsure if current clot reducing medicines are beneficial in preventing blood clots in people having varicose vein procedures. This study will investigate if it is worthwhile prescribing medicines to reduce blood clots after varicose vein procedures.

Conditions

Interventions

TypeNameDescription
DRUGDalteparin SodiumLow molecular weight heparin
DRUGTinzaparin SodiumLow molecular weight heparin
DRUGEnoxaparin SodiumLow molecular weight heparin
DRUGRivaroxabanDirect oral anticoagulant
DRUGApixabanDirect oral anticoagulant
DRUGDabigatran EtexilateDirect oral anticoagulant

Timeline

Start date
2024-01-22
Primary completion
2026-06-30
Completion
2026-12-31
First posted
2023-02-21
Last updated
2025-05-02

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05735639. Inclusion in this directory is not an endorsement.